文献速递产科妇科

滋养细胞微循环封堵作为内源性剖宫产瘢痕妊娠电动负压吸引术的辅助治疗

Trophoblastic microcirculation occlusion as an adjunct to electric vacuum aspiration for the treatment of endogenous cesarean scar pregnancy.
PubMed 文献 · Fertil Steril · 2022-11-28

本研究介绍一种辅助治疗技术——滋养细胞微循环封堵(TMO),通过超声引导下经阴道穿刺注射硬化剂封堵滋养细胞微循环,使内源性剖宫产瘢痕妊娠(CSP)的高风险电动负压吸引术变为常规手术。7例患者均成功实施TMO,术中出血风险显著降低,无围手术期并发症,术后第1天出院,随访未见宫体残留。

要点

  • TMO通过封堵滋养细胞微循环减少CSP电动负压吸引术中出血。
  • 7例患者均成功完成TMO,无围手术期并发症,术后第1天出院。
  • TMO辅助下单次电动负压吸引即可完成治疗,无需子宫动脉栓塞、宫腔镜电切或甲氨蝶呤。

核心结论

  • 在TMO辅助下,内源性CSP的高风险手术流产可在单次电动负压吸引中以极少出血完成。
  • TMO通过超声引导下穿刺即可完成,在生殖医学实践中广泛可用且耗材需求减少。

研究设计与样本

  • 技术展示研究,使用动画、视频片段和幻灯片演示TMO的原理和详细技术,经杭州妇产科医院机构审查委员会批准。
  • 视频展示1例30岁、孕5周的内源性CSP患者,操作步骤在另外6例内源性CSP患者中重复,共7例。
  • 每例患者均签署书面知情同意书。

主要发现

  • TMO在全部7例患者中成功实施,临床结果见表2。
  • TMO显著降低了电动负压吸引术中的出血风险。
  • 围手术期未发现并发症,患者术后第1天出院。
  • 当β-hCG水平降至正常时进行随访超声,未发现任何宫体残留。
  • 1例患者术后7个月获得宫内妊娠,并于孕39周经再次剖宫产分娩一活婴,未见剖宫产瘢痕裂开。

关键数值与推荐

  • TMO治疗中,经肘静脉注射六氟化硫微泡(Bracco,瑞士)行超声造影识别滋养细胞微循环。
  • 使用21G针(长200 mm)经阴道穿刺至合体滋养细胞周围的子宫肌层3个不同点,共注射8 mL硬化剂直接封堵滋养细胞微循环。
  • 完全压迫供应滋养细胞的螺旋动脉是TMO治疗的关键。
  • 注射后重复超声造影确认滋养细胞血流显著减少。
  • TMO治疗后24小时行电动负压吸引术以完全清除妊娠物,术中采用深度镇静和经腹部超声引导。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe a simple adjunct treatment option, trophoblastic microcirculation occlusion (TMO), which could change subsequent high-risk electric vacuum aspiration in patients with an endogenous cesarean scar pregnancy (CSP) into a routine conventional surgical procedure. Electric vacuum aspiration for the treatment of CSP may be associated with several significant complications, including hemorrhage and tissue remnants. Consequently, a second intervention, such as uterine artery embolization, resectoscopy, or methotrexate, may be required, thus complicating the surgical treatment of CSP. DESIGN: We demonstrate the principle and detailed technique of TMO treatment using animations, video clips, and slides. The study was approved by the institutional review board of Hangzhou Women's Hospital. SETTING: Tertiary maternity hospital. PATIENT(S): The video shows a 30-year-old woman with a 5-week endogenous CSP. The procedural steps were repeated in another 6 patients suffering from endogenous CSP (Table 1). Written informed consent was obtained from each patient. INTERVENTION(S): In patients with a CSP, the syncytiotrophoblastic cells erode the helicine arteries in the inner uterine myometrium. The cytotrophoblastic cells extend as villi tissue into the syncytiotrophoblast. Maternal blood enters the intervillous space between the cytotrophoblast and syncytiotrophoblast. The syncytiotrophoblast, cytotrophoblast, and intervillous space constitute the trophoblastic microcirculation, which subsequently becomes the main blood supply to the gestational sac (Fig. 1). During TMO treatment, the trophoblastic microcirculation is identified by contrast-enhanced ultrasound with the cubital vein injected with sulfur hexafluoride microbubbles (Bracco, Switzerland). A 21-gauge needle (200 mm long) was punctured vaginally into the uterine myometrium surrounding the syncytiotrophoblast at 3 different points, and a total of 8 mL sclerosant was injected directly to seal the trophoblastic microcirculation. Complete compression of the helicine arteries for trophoblastic blood supply is the key to TMO treatment (Fig. 2, see video interpretation for detailed information). A repeat contrast-enhanced ultrasound was performed after injection to confirm a significant reduction of blood flow in the trophoblast. An electric vacuum aspiration was performed 24 hours after TMO treatment to remove the products of conception completely. Surgical safety was enhanced by deep sedation and concurrent transabdominal ultrasound guidance. The levels of β-human chorionic gonadotropin (β-hCG) were measured weekly until a nonpregnant level was achieved. A follow-up ultrasound then was performed to confirm that the treatment was complete. MAIN OUTCOME MEASURE(S): The clinical value and feasibility of TMO treatment as an adjunct before high-risk electric vacuum aspiration for the management of endogenous CSP. RESULT(S): The TMO treatment was performed successfully in all 7 patients; the clinical outcomes are presented in Table 2. The TMO treatment significantly reduced the risk of hemorrhage during electric vacuum aspiration. No complications were detected perioperatively. Patients were discharged on day 1 postoperatively. Follow-up ultrasound, performed when the levels of β-hCG had fallen to normal, failed to identify any remnants of the uterine corpus. One patient achieved an intrauterine pregnancy 7 months postoperatively and gave birth to a live baby at 39 weeks of gestation via repeat cesarean section. No cesarean scar dehiscence was observed. CONCLUSION(S): Surgical abortion of an endogenous CSP, with a high risk of intraoperative hemorrhage, can be performed with minimal blood loss in a single electric vacuum aspiration when assisted by TMO treatment. This technique provides good results in terms of bleeding reduction that are comparable to those in conventional patients. The TMO treatment can be accomplished via ultrasound-guided needle puncture, a technique that is available widely in the practice of reproductive medicine with a reduced need for consumable resources. The use of a simple adjunct treatment option, TMO, expands the indications of electric vacuum aspiration. This sequential treatment allows for completion of clinical management without the need for uterine artery embolization, resectoscopy, or methotrexate, thus simplifying the originally complicated form of surgical treatment for CSP.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Sun W, Gao J, Fei X, et al. Trophoblastic microcirculation occlusion as an adjunct to electric vacuum aspiration for the treatment of endogenous cesarean scar pregnancy. Fertil Steril. 2022. PMID: 36456211. doi:10.1016/j.fertnstert.2022.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。